Ines Bleriot
Overview
Explore the profile of Ines Bleriot including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
446
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ibarguren C, Bleriot I, Blasco L, Fernandez-Garcia L, Ortiz-Cartagena C, Arman L, et al.
Microbiol Res
. 2025 Feb;
295:128121.
PMID: 40015081
In the struggle for resources, bacteria have developed different systems of competition, including the type VI secretion system (T6SS) and phage tail-like bacteriocins (PTLBs), that act by killing other bacterial...
2.
Blasco L, Ibarguren-Quiles C, Lopez-Causape C, Arman L, Barrio-Pujante A, Bleriot I, et al.
Microbiol Spectr
. 2025 Feb;
13(3):e0301024.
PMID: 39907445
is a bacterial pathogen that is a major cause of lung infections in cystic fibrosis (CF) and other patients. Isolates of from CF patients commonly carry filamentous phages (Pf phages),...
3.
Pacios O, Herrera-Espejo S, Arman L, Ibarguren-Quiles C, Blasco L, Bleriot I, et al.
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39334989
The combination of several therapeutic strategies is often seen as a good way to decrease resistance rates, since bacteria can more easily overcome single-drug treatments than multi-drug ones. This strategy...
4.
Barrio-Pujante A, Bleriot I, Blasco L, Fernandez-Garcia L, Pacios O, Ortiz-Cartagena C, et al.
Front Microbiol
. 2024 Jul;
15:1416628.
PMID: 38989015
Background: Multidrug-resistant bacteria and the shortage of new antibiotics constitute a serious health problem. This problem has led to increased interest in the use of bacteriophages, which have great potential...
5.
Bleriot I, Pacios O, Blasco L, Fernandez-Garcia L, Lopez M, Ortiz-Cartagena C, et al.
JAC Antimicrob Resist
. 2024 Feb;
6(1):dlae017.
PMID: 38343627
Antibiotic failure is one of the most worrisome threats to global health. Among the new therapeutic efforts that are being explored, the use of bacteriophages (viruses that kill bacteria), also...
6.
Pacios O, Blasco L, Ortiz Cartagena C, Bleriot I, Fernandez-Garcia L, Lopez M, et al.
Front Microbiol
. 2023 Oct;
14:1286046.
PMID: 37886069
Mucins are important glycoproteins that form a protective layer throughout the gastrointestinal and respiratory tracts. There is scientific evidence of increase in phage-resistance in the presence of mucin for some...
7.
Ortiz-Cartagena C, Pablo-Marcos D, Fernandez-Garcia L, Blasco L, Pacios O, Bleriot I, et al.
Microbiol Spectr
. 2023 Jul;
11(4):e0132923.
PMID: 37466441
Carbapenem-resistant pathogens have been recognized as a health concern as they are both difficult to treat and detect in clinical microbiology laboratories. Researchers are making great efforts to develop highly...
8.
Gonzalez de Aledo M, Blasco L, Lopez M, Ortiz-Cartagena C, Bleriot I, Pacios O, et al.
mSphere
. 2023 Jun;
8(4):e0012823.
PMID: 37366636
Prophages are bacteriophages integrated into the bacterial host's chromosome. This research aims to analyze and characterize the existing prophages within a collection of 53 strains from intensive care units (ICUs)...
9.
Bleriot I, Blasco L, Pacios O, Fernandez-Garcia L, Lopez M, Ortiz-Cartagena C, et al.
Microbiol Spectr
. 2023 Mar;
:e0397422.
PMID: 36877024
Phages and bacteria have acquired resistance mechanisms for protection. In this context, the aims of the present study were to analyze the proteins isolated from 21 novel lytic phages of...
10.
Blasco L, Gonzalez de Aledo M, Ortiz-Cartagena C, Bleriot I, Pacios O, Lopez M, et al.
Sci Rep
. 2023 Jan;
13(1):117.
PMID: 36596850
Phage tail-like bacteriocins (PTLBs) are large proteomic structures similar to the tail phages. These structures function in bacterial competition by making pores in the membrane of their competitors. The PTLBs...